Evidence map›Paper›PMID 35243940›Full record

ArticleTechnology in cancer research & treatment

miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.

Wen Cao, Li Ni, Pin Li, Qi-Xia Wang, Ming-Ming Li, Shu-Hong Huang, Ning-Ning Dang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Ubiquitin-conjugating Enzymes in Cancer.International journal of biological sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wen CaoHealth College, Yantai Nanshan University, Yantai, Shandong, China.ORCID 0000-0001-9784-563X
Li NiDepartment of Dermatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Pin LiScience and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China.
Qi-Xia WangInstitute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Ming-Ming LiDepartment of Dermatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Shu-Hong HuangScience and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China.ORCID 0000-0002-7415-2352
Ning-Ning DangDepartment of Dermatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Shandong Provincial Hospital · CNShandong First Medical University · CNYantai Nanshan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MelanomaMicroRNAsUbiquitin-Conjugating EnzymesApoptosisCell Line, TumorCell MovementCell ProliferationCutaneous Malignant MelanomaEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansSkin NeoplasmsMicroRNAsMIRN498 microRNA, humanUBE2T protein, humanUbiquitin-Conjugating EnzymesEMT pathwaymalignant melanomamiR-498UBE2T

Identifiers

PMID35243940
PMCPMC8902009
OpenAlexW4214915351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.